AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Biotechnology

Healthcare
$5.82 +2.48%

+$0.25 today

Market cap
$286.62M
Beta
2.62
P/E (TTM)
-7.1
EPS (TTM)
-$1.28
52W Low $8.75High $17.45

Volume 0.13M

Average 0.14M

Balance Sheet

Inspect the capital base behind the business.

Assets

—

Liabilities

—

Equity

—

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$129.6M
Other Current$3.4M
Total Current Assets$133.0M
PP&E (Net)$1.7M
Goodwill$8.6M
Intangible Assets$20.1M
Long-term Investments$11.0K
Other Non-current$2.2M
Total Non-current Assets$32.6M
Total Assets$165.6M

Analysis

Selected assets total $165.6M for Latest. The largest visible component is Cash & Equivalents at $129.6M, about 78.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 6, 2026
4Statement of changes in beneficial ownershipOct 22, 2026
6-K6-K filingOct 13, 2026
4Statement of changes in beneficial ownershipOct 9, 2026
4Statement of changes in beneficial ownershipOct 7, 2026